Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06211348 · ClinicalTrials.gov registry record · NA
Genomic Sequencing in Anatomically Normal Fetuses
A NA study of Pregnant Individuals Requesting Standard Microarray, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- NA
- Development phase
- 1,000
- Enrollment target
- 1
- Study location
NCT06211348: Recruiting NA study of Pregnant Individuals Requesting Standard Microarray, sponsored by University of California, San Francisco.
NCT06211348 is a NA study of Pregnant Individuals Requesting Standard Microarray that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 1,000 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (29% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06211348, a NA study of Pregnant Individuals Requesting Standard Microarray, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
This cohort study will examine the clinical utility of genomic sequencing (GS) in patients undergoing prenatal diagnostic procedures (chorionic villus sampling or amniocentesis) for routine indications other than a structural fetal anomaly.
Primary Outcome
Proportion of positive genetic diagnosis among all pregnancies with anatomically normal fetuses
Conditions Studied
Interventions
- DEVICE Genomic Sequencing
Study Locations (1)
California
- University of California, San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2024-01-01 |
| Est. Completion | 2030-01 |
| Phase | NA |
What NCT06211348 shows while recruiting
NCT06211348 is an interventional study that assigns participants to a tested intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (29% lower).
The record links to 1 condition, with Pregnant Individuals Requesting Standard Microarray appearing as the primary indexed condition, and to 1 intervention - of which Genomic Sequencing is the first listed.
NCT06211348 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06211348 about?
NCT06211348 is a clinical study titled "Genomic Sequencing in Anatomically Normal Fetuses". This cohort study will examine the clinical utility of genomic sequencing (GS) in patients undergoing prenatal diagnostic procedures (chorionic villus sampling or amniocentesis) for routine indications other than a structural fetal anomaly.
What is the current status of trial NCT06211348?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,000 participants. The study started on 2024-01-01. Estimated completion is 2030-01.
What conditions does trial NCT06211348 study?
This clinical trial studies the following conditions: Pregnant Individuals Requesting Standard Microarray.
What interventions are being tested in trial NCT06211348?
The interventions under investigation include: Genomic Sequencing (DEVICE).
Who is sponsoring clinical trial NCT06211348?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06211348 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06211348's enrollment target sits among peer trials
1,000 107th of 2000 higher than 1,880 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI